Credit Suisse’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $9.15M | Buy |
|
|||||
|
2023
Q4 | $4.18M | Buy |
|
|||||
|
2023
Q3 | $519K | Sell |
|
|||||
|
2023
Q2 | $1.09M | Buy |
|
|||||
|
2023
Q1 | $1.05M | Buy |
|
|||||
|
2022
Q4 | $805K | Buy |
|
|||||
|
2022
Q3 | $689K | Buy |
|
|||||
|
2022
Q2 | $457K | Sell |
|
|||||
|
2022
Q1 | $987K | Buy |
|
|||||
|
2021
Q4 | $1.24M | Buy |
|
|||||
|
2021
Q3 | $975K | Buy |
|
|||||
|
2021
Q2 | $324K | Sell |
|
|||||
|
2021
Q1 | $380K | Sell |
|
|||||
|
2020
Q4 | $677K | Buy |
|